Extending the diabetic retinopathy screening interval beyond 1 year: Systematic review

British Journal of Ophthalmology

Volumn 100, Issue 1, 2016, Pages 105-114

  Taylor Phillips, Sian ^a   Mistry, Hema ^a   Leslie, Rachael ^a   Todkill, Dan ^a   Tsertsvadze, Alexander ^a   Connock, Martin ^a   Clarke, Aileen ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; DIABETIC RETINOPATHY; ECONOMIC EVALUATION; FOLLOW UP; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LOW RISK PATIENT; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SCREENING TEST; SYSTEMATIC REVIEW; UNITED KINGDOM; AGE; COMPLICATION; COST BENEFIT ANALYSIS; DISEASE COURSE; ECONOMICS; FEMALE; MALE; MASS SCREENING; TIME FACTOR;

AGE FACTORS; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; TIME FACTORS;

EID: 84952639553     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-305938     Document Type: Review

References (50)

1. Thomas RL, Dunstan F, Luzio SD, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 2012;344:e874.
2. Saadine JB, Fong DS, Yao J. Factors associated with follow-up eye examinations among persons with diabetes. Retina 2008;28:195-200.
3. Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 2008;15:1-4.
4. Agardh E, Agardh CD, Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 1993;10:555-9.
5. Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000;78:374-85.
6. Javitt JC, Aiello LP, Chiang Y, et al. Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care 1994;17:909-17.
7. Backlund LB, Algvere PV, Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 1997;14:732-40.
8. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124-36.
9. Tung TH, Shih HC, Chen SJ, et al. Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan. J Epidemiol 2008;18:225-33.
10. Scanlon PH, Malhotra R, Greenwood RH, et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthalmol 2003;87:1258-63.
11. Olson JA, Strachan FM, Hipwell JH, et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med 2003;20:528-34.
12. Mitchell P, Foran S, Wong TY, et al. Guidelines for the Management of Diabetic Retinopathy. Australia: Australian Diabetes Society for the National Health & Medical Research Council, 2008. Contract No: 4176.
13. Stefánsson E. Diabetic retinopathy screening. Pediatrics 2006;117:586.
14. Socialstyrelsen. National guidelines for diabetes. Stockholm, Sweden, Socialstyrelsen. 2010. http://wwwsocialstyrelsense (accessed May 2011).
15. Hutchinson A, McIntosh A, Peters J, et al. Clinical guidelines and evidence review for Type 2 diabetes: diabetic retinopathy: early management and screening. Sheffield: ScHARR, University of Sheffield, 2001.
16. Diabetic Retinopathy Summary Benchmark-2013. American Academy of Opthalmology, 2013.
17. Ting D, Ng J, Morlet N, et al. Diabetic retinopathy-screening and management by Australian GPs. Aust Fam Physician 2011;40:233-8.
18. Stratton IM, Aldington SJ. Risk stratification for diabetic eye screening. Diabetologia 2014;57:259.
19. McGhee S, Harding SP, Wong D. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy by Aspelund et al(2011) Diabetologia 54:2525-2532. Graefes Arch Clin Exp Ophthalmol 2012;250:477-8.
20. Echouffo-Tcheugui JB, Ali MK, Roglic G, et al. Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review. Diabet Med 2013;30:1272-92.
21. Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMC Med 2013;11:80.
22. Philips Z, Bojke L, Sculpher M, et al. Good practice guidelines for decision-analytic modelling in health technology assessment. Pharmacoeconomics 2006;24:355-71.
23. Unit PHR. The critical skills appraisal programme: making sense of evidence. England: Public Health Resource Unit, 2006. http://www.casp-uk.net/
24. Steyerberg EW, Moons KG, van der Windt DA, et al. Prognosis research strategy (PROGRESS) 3: prognostic model research. PLoS Med 2013;10:e1001381.
25. Misra A, Bachmann M, Greenwood R, et al. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 2009;26:1040-7.
26. Jones CD, Greenwood RH, Misra A, et al. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 2012;35:592-6.
27. Mehlsen J, Erlandsen M, Poulsen PL, et al. Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol 2011;89:515-21.
28. Mehlsen J, Erlandsen M, Poulsen PL, et al. Individualized optimization of the screening interval for diabetic retinopathy: A new model. Acta Ophthalmol 2012;90:109-14.
29. Kristinsson JK, Gudmundsson JR, Stefansson E, et al. Screening for diabetic retinopathy. Initiation and frequency. Acta Ophthalmol Scand 1995;73:525-8.
30. Olafsdóttir E, Stefánsson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 2007;91:1599-601.
31. Soto-Pedre E, Hernaez-Ortega MC, Vazquez JA. Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus. J Diabetes Sci Technol 2009;3:812-18.
32. Agardh E, Tababat-Khani P. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 2011;34:1318-9.
33. Kohner EM, Stratton IM, Aldington SJ, et al. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med 2001;18:178-84.
34. Maguire A, Chan A, Cusumano J, et al. The case for biennial retinopathy screening in children and adolescents. Diabetes Care 2005;28:509-13.
35. Younis N, Broadbent DM, Harding SP, et al. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med 2003;20:758-65.
36. Younis N, Broadbent DM, Vora JP, et al. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: A cohort study. Lancet 2003;361:195-200.
37. Aspelund T, Thornorisdottir O, Olafsdottir E, et al. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia 2011;54:2525-32.
38. Semeraro F, Parrinello G, Cancarini A, et al. Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complications 2011;25:292-7.
39. Stratton IM, Aldington SJ, Taylor DJ, et al. A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care 2013;36:580-5.
40. Looker HC, Nyangoma SO, Cromie DT, et al. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 2013;56:1716-25.
41. Brailsford SC, Gutjahr WJ, Rauner MS, et al. Combined discrete-event simulation and ant colony optimisation approach for selecting optimal screening policies for diabetic retinopathy. Computational Management Science 2007;4:59-83.
42. Chalk D, Pitt M, Vaidya B, et al. Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy? Diabetes Care 2012;35:1663-8.
43. Dasbach EJ, Fryback DG, Newcomb PA, et al. Cost-effectiveness of strategies for detecting diabetic retinopathy (Structured abstract). Med Care 1991;29:20-39.
44. Davies R, Roderick P, Canning C, et al. The evaluation of screening policies for diabetic retinopathy using simulation. Diabet Med 2002;19:762-70.
45. Javitt J, Canner J, Frank R, et al. Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model. Ophthalmology 1990;97:483-94; discussion 94-5.
46. Rein DB, Wittenborn JS, Zhang X, et al. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res 2011;46:1534-61.
47. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000;283:889-96.
48. Vickers AJ, Cronin AM. Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). Urology 2010;76:1298-301.
49. Jones S, Edwards R. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2009;27:249-56.
50. Mellanby A, Milne R. Research WIfH, Development SD, Committee E. Reducing the interval for diabetic retinal screening. Wessex Institute for Health Research and Development, 1999.